Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsInduction ChemotherapyCombined Modality TherapyPeripheral Blood Stem Cell TransplantationMelphalanMultiple MyelomaTransplantation, HomologousTransplantation ConditioningRemission InductionTreatment OutcomeDisease-Free SurvivalEtoposideSalvage TherapyCyclophosphamideCytarabineStem CellsSurvival RateHodgkin DiseaseLymphoma, Non-HodgkinRecurrenceSurvival AnalysisVincristineMyeloablative AgonistsCarmustineBone Marrow TransplantationHematopoietic Stem Cell MobilizationThiotepaDoxorubicinGraft vs Host DiseaseCisplatinPrognosisBone Marrow PurgingHematologic NeoplasmsAntineoplastic AgentsRetrospective StudiesChemotherapy, AdjuvantIfosfamideLymphoma, Mantle-CellWhole-Body IrradiationDexamethasoneFollow-Up StudiesAmyloidosisHematopoietic Stem CellsBusulfanBoronic AcidsLeukemia, Myeloid, AcutePyrazinesAntineoplastic Agents, AlkylatingAntibodies, Monoclonal, Murine-DerivedGraft SurvivalTime FactorsGranulocyte Colony-Stimulating FactorLymphoma, FollicularAntigens, CD34Lymphoma, T-Cell, PeripheralAutograftsCarboplatinLiver TransplantationThalidomidePrednisoneNeoplasm, ResidualLymphomaIdarubicinLeukapheresisMesenchymal Stem Cell TransplantationDrug Administration ScheduleNeoplasm StagingPodophyllotoxinMaintenance ChemotherapyLymphoma, Large B-Cell, DiffuseMitoxantroneNeoplasm Recurrence, LocalTransplantation ChimeraProspective StudiesMyelodysplastic SyndromesLeukemia, MyeloidTissue DonorsCord Blood Stem Cell TransplantationCell TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaNeutropeniaLymphoma, B-CellFeasibility StudiesKidney TransplantationNeoplasms, Second PrimaryEmbryonic Stem CellsEnteropathy-Associated T-Cell LymphomaBreast NeoplasmsAntibodies, MonoclonalLeukemia, Plasma CellInfusions, SpinalNeoadjuvant TherapyBone MarrowBleomycinAcute DiseaseKaplan-Meier EstimateLife Tables